Benzonatate and Disseminated intravascular coagulation - a phase IV clinical study of FDA data

Summary:

Disseminated intravascular coagulation is reported as a side effect among people who take Benzonatate (benzonatate), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Ondansetron, and have Pain.

The phase IV clinical study analyzes which people have Disseminated intravascular coagulation when taking Benzonatate. It is created by eHealthMe based on reports of 16,665 people who have side effects when taking Benzonatate from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Disseminated intravascular coagulation?

Disseminated intravascular coagulation (systemic activation of blood coagulation) is found to be associated with 1,173 drugs and 1,769 conditions by eHealthMe. Check the latest studies of Disseminated intravascular coagulation.

On Jul, 06, 2026

16,665 people reported to have side effects when taking Benzonatate.
Among them, 19 people (0.11%) have Disseminated intravascular coagulation.

Could Benzonatate cause Disseminated intravascular coagulation?

Among these 19 people:

How long have people been on Benzonatate when they have Disseminated intravascular coagulation? *

What is the gender of people who have Disseminated intravascular coagulation when taking Benzonatate? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Disseminated intravascular coagulation when taking Benzonatate? *

What are other drugs people take besides Benzonatate? *

What are other side effects people have besides Disseminated intravascular coagulation? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 47.37%
Hypotension (abnormally low blood pressure): 7 people, 36.84%
Haemolytic Anaemia (anaemia due to haemolysis): 5 people, 26.32%
Acute Hepatic Failure: 5 people, 26.32%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 26.32%
Cardiac Arrest: 4 people, 21.05%
Blood Creatinine Increased: 4 people, 21.05%
Acute Kidney Failure: 4 people, 21.05%
Fever: 4 people, 21.05%
Blood Glucose Increased: 4 people, 21.05%

What are the existing conditions these people have? *

Pain: 5 people, 26.32%
Nausea (feeling of having an urge to vomit): 3 people, 15.79%
Breast Cancer Metastatic: 3 people, 15.79%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 15.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
Hypersensitivity: 2 people, 10.53%
Breast Cancer Stage Iv: 2 people, 10.53%
Sleep Disorder: 1 person, 5.26%
Rosacea (a skin condition that causes facial redness): 1 person, 5.26%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and have Disseminated intravascular coagulation?

- Check whether Disseminated intravascular coagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzonatate:

Benzonatate (17,274 reports)

Disseminated intravascular coagulation treatments and more:

Disseminated intravascular coagulation (24,199 reports)

How severe was Disseminated intravascular coagulation and when was it recovered:

Disseminated intravascular coagulation in Benzonatate

Expand to all the drugs that have ingredients of benzonatate:

Disseminated intravascular coagulation and drugs with ingredients of benzonatate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disseminated intravascular coagulation:

Disseminated intravascular coagulation (1,173 drugs)

Browse all the conditions that are associated with Disseminated intravascular coagulation:

Disseminated intravascular coagulation (1,769 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate (the active ingredients of Benzonatate) and Benzonatate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.